Kyowa Kirin
4151.TPharmaceutical
Filed as Kyowa Kirin Co., Ltd. (2022-08–2026-08)
Financials · Consolidated
| Fiscal year ended | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
|---|---|---|---|---|---|---|
| Revenue | ¥496.8bn | ¥495.6bn | ¥442.2bn | ¥398.4bn | ¥352.2bn | ¥318.4bn |
| Net income (owners) | ¥67.0bn | ¥59.9bn | ¥81.2bn | ¥53.6bn | ¥52.3bn | ¥47.0bn |
| Total assets | ¥1.11T | ¥1.07T | ¥1.03T | ¥939.9bn | ¥921.9bn | ¥801.3bn |
| Net assets / equity | ¥893.3bn | ¥850.8bn | ¥836.4bn | ¥762.8bn | ¥737.2bn | ¥698.4bn |
| Operating cash flow | ¥96.6bn | ¥67.9bn | ¥115.6bn | ¥48.7bn | ¥86.5bn | ¥39.5bn |
| EPS (basic) | ¥128.07 | ¥113.06 | ¥151.03 | ¥99.68 | ¥97.43 | ¥87.56 |
From EDINET filings. Select any figure to open the report it came from. r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.
Reports · 6
| Period | Form | Figures |
|---|---|---|
| 2024-01-01 → 2024-03-31 | Quarterly Q1 | 78 figures · EDINET |
| 2023-01-01 → 2023-09-30 | Quarterly Q3 | 98 figures · EDINET |
| 2023-01-01 → 2023-06-30 | Quarterly Q2 | 96 figures · EDINET |
| 2023-01-01 → 2023-03-31 | Quarterly Q1 | 76 figures · EDINET |
| 2022-01-01 → 2022-09-30 | Quarterly Q3 | 98 figures · EDINET |
| 2022-01-01 → 2022-06-30 | Quarterly Q2 | 98 figures · EDINET |
23 more reports are still being processed.